Cizzle Biotechnology (LON:CIZ) Posts Quarterly Earnings Results

Cizzle Biotechnology (LON:CIZ) posted its quarterly earnings data on Wednesday. The company reported GBX (0.08) earnings per share for the quarter, Digital Look Earnings reports.

Cizzle Biotechnology Stock Down 13.8%

CIZ opened at GBX 1.47 on Wednesday. Cizzle Biotechnology has a 52 week low of GBX 1.20 and a 52 week high of GBX 3.90. The business has a fifty day simple moving average of GBX 1.67 and a 200-day simple moving average of GBX 2.23. The firm has a market cap of £6.23 million, a P/E ratio of -8.62 and a beta of 0.02.

About Cizzle Biotechnology

Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.